Default company panoramic image

Phytonix Corporation

Phytonix's photobiological technology uses biosafe microbial nanofactories, converting CO2 to low cost, high value chemicals & biofuel (butanol & pentanol).

  • Stage Prototype Ready
  • Industry Industrial/Energy
  • Location Asheville, NC, USA
  • Currency USD
  • Founded July 2009
  • Employees 2
  • Website

Company Summary

Phytonix Corp. is prototype stage. Our proprietary IP uses synthetic biology to create biosafe n-butanol and pentanol secreting microbial factories w/ carbon dioxide as the sole feedstock & oxygen as the byproduct. Our distributed, capital-light business model achieves breakthrough results with world-class scientific partners. Current market size is $9 B. Our process is highly carbon-negative, displacing a fossil-based, carbon-intensive process.


  • Default avatar
    Bruce Dannenberg
    Founder, President & CEO

  • Default avatar
    Peter Lindblad
    Microbial Technology Development Leader

  • Default avatar
    Gary Anderson
    Photobioreactor Technology Development Leader

  • Default avatar
    Soody Tronson
    Senior Legal and IP Counsel

Previous Investors

  • Default avatar
    To date Phytonix has raised $876,000 from accredited investors